Correlation Engine 2.0
Clear Search sequence regions


  • amyloid (2)
  • humans (1)
  • mammals (1)
  • mice (5)
  • P301S (4)
  • patients (1)
  • rodent (1)
  • tau Proteins (2)
  • Sizes of these terms reflect their relevance to your search.

    Interval timing is a key executive process that involves estimating the duration of an interval over several seconds or minutes. Patients with Alzheimer's disease (AD) have deficits in interval timing. Since temporal control of action is highly conserved across mammalian species, studying interval timing tasks in animal AD models may be relevant to human disease. Amyloid plaques and tau neurofibrillary tangles are hallmark features of AD. While rodent models of amyloid pathology are known to have interval timing impairments, to our knowledge, interval timing has not been studied in models of tauopathy. Here, we evaluate interval timing performance of P301S transgenic mice, a widely studied model of tauopathy that overexpresses human tau with the P301S mutation. We employed an interval timing task and found that P301S mice consistently underestimated temporal intervals compared to wild-type controls, responding early in anticipation of the target interval. Our study indicating timing deficits in a mouse tauopathy model could have relevance to human tauopathies such as AD. Copyright © 2022. Published by Elsevier B.V.

    Citation

    Travis Larson, Vaibhav Khandelwal, Matthew A Weber, Mariah R Leidinger, David K Meyerholz, Nandakumar S Narayanan, Qiang Zhang. Mice expressing P301S mutant human tau have deficits in interval timing. Behavioural brain research. 2022 Aug 26;432:113967

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35718229

    View Full Text